John Alm, DO
Physical Medicine & Rehabilitation · Columbia, MONPI 1639466220
Payments from drug & device makers
What this record shows
9 manufacturers reported payments, led by AbbVie at 55.7% of the total. 2025 is the largest year on record at $1,658, 8.1 times the $204 reported in 2019.
Across 31 payments — averaging $109.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Abbott$768
- Pacira Pharmaceuticals Incorporated$243
- Microtransponder, Inc.$220
- Si-bone, Inc.$114
- Merz North America, Inc.$75
- plus $78 from 3 others
What the payments were for
- Travel & lodging$1,72151%
- Food & beverage$1,66449%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 14 | $1,887 |
| Abbott | 8 | $768 |
| Pacira Pharmaceuticals Incorporated | 3 | $243 |
| Microtransponder, Inc. | 1 | $220 |
| Si-bone, Inc. | 1 | $114 |
| Merz North America, Inc. | 1 | $75 |
| Merz Pharmaceuticals, LLC | 1 | $44 |
| SPR Therapeutics, Inc | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$1,405
- Proclaim Family of SCS IPGs$529
- Iovera$216
How this compares
$3,385 in reported general payments places this provider in the 85th percentile of 182 physical medicine & rehabilitation providers in Missouri.
See all physical medicine & rehabilitation providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 73 | $1,227 |
| Gabapentin | 48 | $823 |
| Celecoxib | 27 | $494 |
| Duloxetine Hcl | 24 | $421 |
| Baclofen | 15 | $316 |
| Meloxicam | 54 | $268 |
| Tizanidine Hcl | 12 | $50 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Columbia
- Joseph BurrisColumbia$75K
- Jane EmersonColumbia$44K
- Reza FaridColumbia$37K
- Vovanti JonesColumbia$9K
- Rachael BrashearsColumbia$7K
- Hannah FarmerColumbia$4K
- Nicholas MadafferColumbia$3K
- Mark DrymalskiColumbia$992
- Megan ClarkColumbia$564
- Kevin ThomasColumbia$399
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.